Sushmita Roy is a Professor at the University of Wisconsin–Madison, affiliated with the Department of Computer Sciences and the College of Letters and Science. Her research focuses on developing computational methods in statistical machine learning to understand gene regulatory networks in living cells, particularly under environmental, developmental, disease, and evolutionary contexts. She explores bulk and single-cell genomic data integration to study processes like cell fate specification, host-microbe interactions, and diseases such as cancer and neurodevelopmental disorders. Her work emphasizes three key areas: inference of genome-scale transcriptional networks, evolutionary analysis of regulatory networks, and 3D genome organization dynamics. Roy’s lab collaborates across disciplines, leveraging genomic data from plant and mammalian systems. She has contributed to methodologies for analyzing chromatin accessibility, single-cell profiling, and network-based models of pathogen systems. Her affiliations include Wisconsin Institutes for Discovery, and she is a leader in computational biology and systems genomics research.
Ronald J. Colombo is Professor of Law and Associate Dean for Distance Education at Hofstra University's Maurice A. Deane School of Law. He teaches courses in Business Organizations, Securities Regulation, Contracts, and corporate law seminars. He has been on the faculty since 2006 and previously served as Associate Dean for Academic Affairs (2013–2015). Education: JD, New York University School of Law (magna cum laude, Order of the Coif), 1998 BS, Cornell University, 1994 Clerkship: Judge Jerry E. Smith, U.S. Court of Appeals for the Fifth Circuit Professor Colombo’s research focuses on corporate law, securities regulation, financial regulation, and the constitutional rights of corporations, especially First Amendment protections. His work explores the moral and philosophical underpinnings of corporate personhood, religious liberty in business, and the role of trust in financial systems. He is particularly known for bridging legal doctrine with ethical and theological perspectives. His recent scholarly publications reveal a strong thematic trend: the intersection of religion, corporate governance, and constitutional law. He has also contributed to legal education, especially in online teaching methodologies, and continues to publish on financial regulation and corporate ethics. Scientific Awards: Stessin Prize for Outstanding Scholarly Publication Lawrence A. Stessin Prize for Outstanding Scholarly Publication (2008) Professor Colombo has been actively involved in professional service, including serving on the editorial review board of the Review of Business and as an arbitrator for the Financial Industry Regulatory Authority (FINRA). He has not listed any formal research grants or PhD students, but his influence extends through media engagement—quoted in The New York Times , Wall Street Journal , and Bloomberg —and through his widely read op-eds in The Financial Times and Huffington Post . He has held leadership roles in academic administration and is a recognized expert in both practitioner and scholarly legal communities. His treatise Law of Corporate Officers and Directors is republished annually by Thomson Reuters, indicating sustained scholarly and practical impact.
Rachel Rudinger is an Assistant Professor at the University of Maryland, affiliated with the Department of Computer Science and the University of Maryland Institute for Advanced Computer Studies (UMIACS). Her research focuses on Natural Language Processing (NLP), Machine Learning, and AI ethics, particularly addressing sociocultural biases and fairness in large language models (LLMs). She holds a PhD from Johns Hopkins University (2019) and a B.S. from Yale University (2013). Rudinger's work explores equitable cultural alignment in AI systems, common ground misalignment in dialog systems, and the mutual influence of gender and occupation in LLMs. She received the NSF CAREER Award in 2024 for her project on robust, fair, and culturally aware commonsense reasoning. Her recent publications investigate empathy gaps in LLMs, synthetic data effectiveness in disaster response, and bias measurement techniques across domains. As an advisor, she guides seven PhD students including Christabel Acquaye and Haozhe An. Her research spans diverse topics from legal language analysis to maternal health question answering, reflecting her commitment to interdisciplinary AI ethics. She actively contributes to workshops on commonsense representation and serves as a reviewer for top conferences in NLP and AI.
Deborah Richards is a Professor in the School of Computing at Macquarie University, affiliated with the Ethics and Agency Research Centre, Performance and Expertise Research Centre, and Frontier AI Research Centre. She holds roles as Industry and External Relations Director for the School and Director of the Virtual Reality Lab. Her research focuses on Intelligent Virtual Agents, Virtual Reality applications in education and health, knowledge acquisition, and cybersecurity ethics. She has authored over 425 publications and led 19 research projects, including studies on AI in healthcare and ethical AI design. Education: PhD (Artificial Intelligence, Macquarie University), MAppSc (Information Studies), BBus (Computing and MIS), and a Postgraduate Certificate in Higher Education (Leadership and Management). She advises on PhD and MRes students in Intelligent Virtual Agents research. Research interests include virtual agents for health behavior change, AI ethics, and educational technology. Notable projects include the eADVICE web-based management system for urinary incontinence and the development of embodied conversational agents for wellbeing support. Awards include the ABC Science Media Fellowship (2005) and Vice-Chancellor’s Citations for Outstanding Contributions to Student Learning (2017). Grants and collaborations span health informatics, cybersecurity, and AI ethics. She co-leads initiatives like the Respectful Maternity Care study and the Virtual Reality Lab’s immersive learning environments. Future work emphasizes ethical AI integration in education and healthcare.
Megan S. Ryerson holds the UPS Chair of Transportation and serves as Associate Chair of City and Regional Planning at the University of Pennsylvania's Stuart Weitzman School of Design. Previously, she was Associate Dean for Research (2018–2023), demonstrating sustained leadership in academic administration while maintaining an active research profile focused on transportation systems integration. Her educational credentials include: Ph.D. in Civil and Environmental Engineering, University of California, Berkeley (2010) B.Sc. in Systems Engineering, University of Pennsylvania (2003) Ryerson's research pioneers the integration of intercity transportation into urban planning frameworks, with foundational work in aviation infrastructure planning , airline demand forecasting , and transportation resilience . She investigates airport competition dynamics across megaregions, airline disaster recovery protocols, and fuel-efficient flight planning methodologies. Her scholarship actively bridges civil engineering and urban planning disciplines to design transportation systems that are inherently safe , efficient , and resilient against disruptions. Analysis of her 15 most recent publications reveals a pronounced shift toward transportation equity since 2022, particularly examining driver education accessibility ('driver training deserts') and bikeshare infrastructure allocation. This equity focus coexists with continued aviation research, while pandemic-era studies on transportation behavior (2020–2023) demonstrate methodological adaptability through quasi-experimental designs and real-world crisis response analysis. Her scientific recognition includes: UPS Chair of Transportation (prestigious endowed professorship) Dr. Ryerson has significantly expanded urban planning pedagogy by incorporating megaregional transportation systems into core curricula. Her leadership as former Associate Dean for Research reflects active engagement with funding agencies and research administration, though specific grant details aren't documented in source materials. Current work emphasizes translating research into equitable policy frameworks, particularly for vulnerable transportation populations.
Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Lorin Schöni is a PhD candidate at ETH Zürich, actively contributing to the Security, Privacy and Society research group since October 2022. Concurrently, he serves as a Lecturer at the Department of Humanities, Social and Political Sciences, where he teaches the course Focus on the Human: Human-Centered Security and Privacy Lab (Autumn Semester 2025, Unit 851-0391-00L). His research focuses on human-centered approaches to cybersecurity , particularly through three key domains: Human-Computer Interaction - Investigating design decisions that influence user behavior in digital security contexts Extended Reality Applications - Developing immersive training systems for phishing prevention Usability Engineering - Creating intuitive security interfaces with explainable AI components Recent publications highlight his work at the intersection of autonomous motivation theory and personalized cybersecurity training , with notable presentations at top venues including CHI 2025 and SOUPS 2024. His research aims to transform security from a restrictive framework into a collaborative partnership between users and digital systems, as emphasized in his award-winning work on human-centered cybersecurity.
Prof. Anya Belz is Full Professor of Computer Science at Dublin City University's School of Computing and Science Lead at ADAPT Research Centre. A leading NLP researcher with PhD-level expertise, she specializes in natural language generation, evaluation methodologies, and multimodal systems. Recipient of multiple best paper awards and NAACL Test of Time Award nomination. Research innovations include foundational work on statistical language generation (deployed in weather forecasting systems), comparative evaluation frameworks, vision-language integration, and reproducibility quantification. Current EPSRC-funded ReproHum project coordinates 20 global labs studying evaluation consistency. Achievements : Developed industry-deployed generation systems for accessibility applications Pioneered cross-modal alignment techniques for image description Authored 100+ publications spanning generation, evaluation, and reproducibility
Arash Arami is an Associate Professor in the Department of Mechanical and Mechatronics Engineering at the University of Waterloo, cross-appointed in Systems Design Engineering. He directs the Neuromechanics and Assistive Robotics Laboratory and maintains affiliations with Waterloo Robohub, the Centre for Bioengineering and Biotechnology, Waterloo AI institute, and KITE institute at Toronto Rehab Institute. He earned his Doctorate in Electrical Engineering from EPFL (2014), Master of Science from University of Tehran (2009), and Bachelor of Science from University of Tabriz (2006), all in Control Engineering. His research in Assistive Robotics and Rehabilitation Engineering integrates Machine Learning with Neuromechanics to develop intelligent systems for human movement analysis. Key focus areas include exoskeleton control algorithms, wearable sensor systems, and neural control modeling for rehabilitation applications. Recent publications demonstrate interdisciplinary work spanning robotics, biomedical engineering, and materials science, with emphasis on real-time human locomotion prediction, exoskeleton-human interaction, and data-driven health monitoring solutions. Dr. Arami serves as Chair of the NSERC Scholarship Committee (2021-2023) and mentors graduate students through the Mechatronics Exchange Study program. His teaching includes core courses in control systems, robot manipulators, and biomechanical engineering. The Neuromechanics and Assistive Robotics Laboratory fosters collaborations with clinical partners at Toronto Rehab Institute, focusing on translating robotic innovations into practical rehabilitation tools through interdisciplinary teamwork.
Karoline Faust is an Associate Professor at KU Leuven, affiliated with the Laboratory of Molecular Bacteriology (Rega Institute) and the Faculty of Medicine . She contributes to the iSi Health and Leuven One Health institutes, and serves on senior academic councils. Her research spans microbial systems biology, focusing on community dynamics and network analysis. Education: PhD in bioinformatics (2010, KU Leuven) Affiliations: KU Leuven, ISME Journal editorial board, Belgian Society for Microbiology Her research investigates microbial community dynamics , systems biology approaches to microbiomes, and bioinformatics tool development . She specializes in modeling human gut microbiota , synthetic microbial communities , and environmental microbiomes (e.g., microplastic impacts on Daphnia microbiomes). Her work integrates metabolic modeling , network analysis , and experimental systems to understand microbial interactions. Recent publications highlight her contributions to microbial network inference , 16S rRNA sequencing protocols , microfluidics , and ecological modeling of microbiomes. She develops tools like manta , miaSim , and CoNet to analyze community structures. Teaching: Karoline co-teaches courses in microbiology, bioinformatics, and network analysis at KU Leuven, and has contributed to international workshops on microbial network inference. Scientific Engagement: She serves as Senior Editor at ISME Journal and Secretary of the Belgian Society for Microbiology .
Massimo Mischi is a Full Professor at the Faculty of Electrical Engineering of the Eindhoven University of Technology (TU/e) and chairs the Signal Processing Systems (SPS) Division , the largest division at TU/e with over 250 researchers. He founded the Biomedical Diagnostics (BM/d) Lab in 2012, which now includes 180 researchers and clinical/industrial advisors, focusing on biomedical signal processing for diagnostics and monitoring.
Nebiyou Tilahun is an Associate Professor and Director of Graduate Studies in the Department of Urban Planning and Policy at the University of Illinois at Chicago (UIC), within the College of Urban Planning and Public Affairs (CUPPA). He leads the Mobility Urban Systems and Equity Lab , focusing on equitable transportation solutions. His roles include teaching courses such as Transportation Planning Methods, Spatial Statistics, and Plan Making Studio. Dr. Tilahun holds a PhD in Civil Engineering from the University of Minnesota (2010), with earlier degrees in Civil Engineering (B.Sc., 2001; M.Sc., 2005). His career includes post-doctoral research at UIC’s Urban Transportation Center and the University of Minnesota’s Humphrey School of Public Affairs, as well as professional experience at the Washington State Department of Transportation. Research Interests : His work bridges transportation equity, urban planning, and policy evaluation. Key areas include: Transport accessibility and equity Automated traffic enforcement (e.g., speed/red-light cameras) Social networks and travel behavior Disability and mobility challenges Intergenerational poverty and spatial mobility Recent Research Trends : His publications emphasize equity in urban systems, such as analyzing racial disparities in traffic stops, evaluating automated camera efficacy, and exploring how residential choices shape young adults’ travel patterns. He also investigates transit accessibility gaps in Chicago and the role of technology in urban informatics. Labs/Teams : Directs the Mobility Urban Systems and Equity Lab, which develops tools like the Chicago Accessibility Explorer to visualize transit equity. Collaborates on projects like Seeing Cities Through Big Data , applying data science to urban planning challenges. Grants/Advising : While specific grants are not detailed here, his lab’s work implies funding in transportation equity and technology. No advisees are listed in the provided materials.
Annette Juul Vangsted serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her clinical specialization is in Internal Medicine with a focus on Hematology, specifically multiple myeloma. Based at Blegdamsvej 9 in Copenhagen, she maintains an active research profile with 67 documented research outputs and extensive collaborations across Nordic countries and internationally. Dr. Vangsted's research primarily centers on multiple myeloma, with particular emphasis on genetic predisposition, treatment outcomes, epidemiological patterns, and bone disease management. Her work bridges clinical practice with genetic research, examining how genetic variants influence disease risk and progression. She investigates geographical variations in myeloma incidence and outcomes, as well as novel treatment approaches for elderly patients and those with specific genetic profiles. Analysis of her recent publications reveals a clear focus on multiple myeloma across several dimensions: genetic susceptibility (including large genome-wide association studies), treatment efficacy (particularly regarding bone disease management), epidemiological patterns across Nordic countries, and specialized care for elderly populations. Her collaborative approach is evident through numerous multi-center studies involving Nordic Myeloma Study Group and international research teams. Dr. Vangsted actively participates in clinical research through the Nordic Myeloma Study Group, contributing to registry studies and clinical trials that inform treatment guidelines for multiple myeloma. Her work has significant implications for understanding disease mechanisms and improving patient outcomes, particularly in the areas of genetic risk assessment and personalized treatment approaches. She maintains strong research collaborations across Denmark, Sweden, and international institutions, with particular focus on hematological malignancies. Her laboratory and clinical research team works within the Department of Clinical Medicine's hematology division, focusing on translational research that directly impacts clinical practice for myeloma patients.
Eugenia Rho is an Assistant Professor in the Department of Computer Science at Virginia Polytechnic Institute and State University (Virginia Tech), part of the College of Engineering. Her research focuses on data analytics, machine learning, natural language processing, and human-computer interaction, with particular emphasis on social media discourse, online identity dynamics, and ethical AI applications. Education includes a Ph.D. in Information and Computer Sciences from the University of California, Irvine (2020), and a B.A. in Political Science from Columbia University (2011). Her interdisciplinary background bridges computer science and social sciences. Research interests span AI-assisted communication tools, counterspeech strategies for online hate mitigation, and neurodivergent perspectives in technology design. Her work often integrates computational methods with social science theories to address real-world challenges such as bias detection, mental health support, and ethical AI deployment. Recent publications highlight themes like AI collaboration in writing, identity-driven online interactions, and the efficacy of counterspeech. Her projects frequently involve designing human-centered technologies that prioritize accessibility and ethical considerations. No scientific awards are explicitly mentioned in the provided text. She maintains an active Google Scholar profile and a personal homepage (URLs not provided in the text).
